Suppr超能文献

使用CT和MRI评估肝硬化时肝脏表面结节量化的可行性和可重复性

Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI.

作者信息

Lo Grace C, Besa Cecilia, King Michael J, Kang Martin, Stueck Ashley, Thung Swan, Wagner Mathilde, Smith Andrew D, Taouli Bachir

机构信息

Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Eur J Radiol Open. 2017 Jul 21;4:95-100. doi: 10.1016/j.ejro.2017.07.001. eCollection 2017.

Abstract

PURPOSE

To assess intra-observer, inter-observer and inter-modality (CT vs. MRI) reproducibility of liver surface nodularity (LSN) scores measured with software used for detection of liver fibrosis.

METHODS

This IRB-approved retrospective study included patients with both abdominal CT and MRI within 6 months of histopathologic sampling. Two independent observers used post-processing software to quantify LSN scores on axial non-contrast CT (NCT), axial contrast-enhanced CT (CECT), axial T2-weighted (T2W) HASTE, and axial and coronal post-gadoxetic acid T1-weighted (T1W) images obtained during the hepatobiliary phase (HBP). Ten slices were used to acquire the LSN scores. Intra-observer, inter-observer, and inter-modality (CT vs. MRI) reproducibility were assessed with intraclass correlation coefficient (ICC) and coefficients of variability (CV). Accuracy for detection of cirrhosis was evaluated for each technique.

RESULTS

26 patients (M/F 19/7, mean age 57 years), including 7 with cirrhosis (26.9%), were assessed. Technical failure occurred with NCT (1/23, 4.3%) and T2 HASTE (8/28, 28.6%). Intra-observer reproducibility was excellent for NCT, CECT, axial and coronal T1W HBP [ICC ≥ 0.92, CV ≤ 8%]. Inter-observer reproducibility was also excellent for NCT and CECT (ICC ≥ 0.95, CV ≤ 7.3%) and for coronal T1W HBP (ICC = 0.84, CV = 5.6%). There was fair to moderate agreement between CT and MRI (ICC 0.20-0.44). There were significant differences in mean LSN scores between non-cirrhotic and cirrhotic patients with NCT (2.6 vs. 4.2, p = 0.04) and T1W HBP (3.7 vs. 4.6; p = 0.01) images, with AUCs of 0.81 and 0.82, respectively.

CONCLUSIONS

LSN measurement is highly reproducible with NCT and post-contrast T1W HBP on MRI, with different results obtained between CT and MRI.

摘要

目的

评估使用用于检测肝纤维化的软件测量肝脏表面结节性(LSN)评分时观察者内、观察者间以及不同模态(CT与MRI)之间的可重复性。

方法

这项经机构审查委员会(IRB)批准的回顾性研究纳入了在组织病理学采样6个月内同时接受腹部CT和MRI检查的患者。两名独立观察者使用后处理软件对轴向平扫CT(NCT)、轴向增强CT(CECT)、轴向T2加权(T2W)HASTE序列以及肝胆期(HBP)获得的轴向和冠状位钆塞酸增强T1加权(T1W)图像上的LSN评分进行量化。使用十层图像来获取LSN评分。通过组内相关系数(ICC)和变异系数(CV)评估观察者内、观察者间以及不同模态(CT与MRI)之间的可重复性。对每种技术检测肝硬化的准确性进行评估。

结果

共评估了26例患者(男/女19/7,平均年龄57岁),其中7例患有肝硬化(26.9%)。NCT(1/23,4.3%)和T2 HASTE序列(8/28,28.6%)出现技术失败。NCT、CECT、轴向和冠状位T1W HBP序列的观察者内可重复性极佳[ICC≥0.92,CV≤8%]。NCT和CECT序列(ICC≥0.95,CV≤7.3%)以及冠状位T1W HBP序列(ICC = 0.84,CV = 5.6%)的观察者间可重复性也极佳。CT与MRI之间的一致性为中等至良好(ICC 0.20 - 0.44)。在NCT(2.6对4.2,p = 0.04)和T1W HBP序列(3.7对4.6;p = 0.01)图像上,非肝硬化患者与肝硬化患者的平均LSN评分存在显著差异,曲线下面积(AUC)分别为0.81和0.82。

结论

NCT以及MRI上的钆塞酸增强后T1W HBP序列对LSN的测量具有高度可重复性,CT与MRI之间结果不同。

相似文献

1
Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI.
Eur J Radiol Open. 2017 Jul 21;4:95-100. doi: 10.1016/j.ejro.2017.07.001. eCollection 2017.
3
Precision analysis of a quantitative CT liver surface nodularity score.
Abdom Radiol (NY). 2018 Dec;43(12):3307-3316. doi: 10.1007/s00261-018-1617-x.
4
Reproducibility of MRI-derived liver surface nodularity score: analysis of patients with repeated MRI in various scanners.
Abdom Radiol (NY). 2023 Feb;48(2):590-600. doi: 10.1007/s00261-022-03744-6. Epub 2022 Nov 23.
5
Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.
Radiology. 2016 Sep;280(3):771-81. doi: 10.1148/radiol.2016151542. Epub 2016 Apr 18.
7
Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
Eur Radiol. 2019 Nov;29(11):5852-5860. doi: 10.1007/s00330-019-06113-y. Epub 2019 Mar 19.
9
Regional Analysis of Liver Surface Nodularity in a Single Axial MR Image for Staging Liver Fibrosis.
J Magn Reson Imaging. 2022 Dec;56(6):1781-1791. doi: 10.1002/jmri.28208. Epub 2022 May 11.
10
Intraindividual comparison of MRI-derived liver surface nodularity score at 1.5 T and 3 T.
Abdom Radiol (NY). 2022 Mar;47(3):1053-1060. doi: 10.1007/s00261-022-03415-6. Epub 2022 Jan 21.

引用本文的文献

2
Fully Automated and Explainable Measurement of Liver Surface Nodularity in CT: Utility for Staging Hepatic Fibrosis.
Acad Radiol. 2025 Mar;32(3):1398-1408. doi: 10.1016/j.acra.2024.09.050. Epub 2024 Oct 8.
3
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis.
Biomater Res. 2024 Jul 1;28:0042. doi: 10.34133/bmr.0042. eCollection 2024.
4
The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients.
Eur J Hybrid Imaging. 2023 Oct 16;7(1):19. doi: 10.1186/s41824-023-00173-6.
5
Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): An International Multicenter Study.
J Clin Transl Hepatol. 2021 Dec 28;9(6):818-827. doi: 10.14218/JCTH.2021.00177. Epub 2021 Sep 30.
6
Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques.
Abdom Radiol (NY). 2022 Sep;47(9):3051-3067. doi: 10.1007/s00261-021-03181-x. Epub 2021 Jul 6.
7
Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease.
Abdom Radiol (NY). 2021 Sep;46(9):4189-4199. doi: 10.1007/s00261-021-03113-9. Epub 2021 May 12.
10
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease.
World J Gastroenterol. 2020 Oct 21;26(39):5919-5943. doi: 10.3748/wjg.v26.i39.5919.

本文引用的文献

1
Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.
Radiology. 2017 Jun;283(3):711-722. doi: 10.1148/radiol.2016160799. Epub 2016 Nov 3.
2
Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.
AJR Am J Roentgenol. 2016 Dec;207(6):1194-1199. doi: 10.2214/AJR.16.16514. Epub 2016 Aug 30.
3
Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.
Radiology. 2016 Sep;280(3):771-81. doi: 10.1148/radiol.2016151542. Epub 2016 Apr 18.
6
Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography.
Abdom Imaging. 2015 Apr;40(4):766-75. doi: 10.1007/s00261-015-0347-6.
7
Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment.
Stat Methods Med Res. 2015 Feb;24(1):27-67. doi: 10.1177/0962280214537344. Epub 2014 Jun 11.
8
Magnetic resonance elastography of liver: technique, analysis, and clinical applications.
J Magn Reson Imaging. 2013 Mar;37(3):544-55. doi: 10.1002/jmri.23731.
9
Accuracy of routine clinical ultrasound for staging of liver fibrosis.
J Clin Imaging Sci. 2012;2:58. doi: 10.4103/2156-7514.101000. Epub 2012 Sep 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验